Effect of smoking on orbital fat and muscle volume in Graves' orbitopathy

Thyroid

Volumn 21, Issue 2, 2011, Pages 177-181

  Regensburg, Noortje I ^a   Wiersinga, Wilmar M ^a   Berendschot, Tos T J M ^b   Saeed, Peerooz ^a   Mourits, Maarten P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ABDUCTION; ADDUCTION; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BODY FAT; CASE STUDY; CIGARETTE SMOKING; COMPUTER PROGRAM; CONTROLLED STUDY; DIPLOPIA; ENDOCRINE OPHTHALMOPATHY; EXTRAOCULAR MUSCLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; OBSERVATIONAL STUDY; ORBITAL FAT; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL;

ADULT; ANOXIA; BODY FAT DISTRIBUTION; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; GRAVES OPHTHALMOPATHY; HUMANS; LIPID METABOLISM; MIDDLE AGED; MUSCLE, SKELETAL; ORBIT; ORGAN SIZE; SMOKING;

EID: 79953244435     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.0218     Document Type: Article

References (24)

1. Vestergaard P, Rejnmark L, Weeke J, Hoeck HC, Nielsen HK, Rungby J, Laurberg P, Mosekilde 2002 Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid 12:69-75. (Pubitemid 34106719)
2. Hegedius L, Brix TH, Vestergaard P 2004 Relationship between cigarette smoking and Graves' ophthalmopathy. J Endocrinol Invest 27:265-271. (Pubitemid 38607480)
3. Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell'Unto E, Bartolomei MP, Nardi M, Martino E, Pinchera A 1998 Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med 129:632-650.
4. Krassas GE, Wiersinga W 2006 Smoking and autoimmune thyroid disease: the plot thickens. Eur J Endocrinol 154:777-780. (Pubitemid 43997713)
5. Thornton J, Kelly SP, Harrison RA, Edwards R 2007 Cigarette smoking and thyroid eye disease: a systematic review. Eye 21:1135-1145. (Pubitemid 47382137)
6. Kahaly G, Forster G, Hansen C 1998 Glycosaminoglycans in thyroid eye disease. Thyroid 8:429-432. (Pubitemid 28252428)
7. Mack WP, Stasior GO, Cao HJ, Stasior OG, Smith TJ 1999 The effect of cigarette smoke constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves ophthalmopathy. Ophthal Plast Reconstr Surg 15:260-271.
8. Cawood TJ, Moriarty P, O'Farrelly C, O'Shea D 2007 Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link. J Clin Endocrinol Metab 92:59-64. (Pubitemid 46067509)
9. Regensburg NI, Wiersinga WM, Berendschot TJJM, Potgieser P, Mourits MP 2010 Do subtypes of Graves' orbitopathy exists. Ophthalmology Jul 27 [Epub ahead of print]. PMID: 20673587.
10. Regensburg NI, Wiersinga WM, Velthoven MEJ van, Berendschot TTJM, Zonneveld FW, Baldeschi L, Saeed P, Mourits MP 2010 Age- and gender specific reference values of orbital fat- and muscle volumes in Caucasians. Br J Ophthalmol Jun 7 [Epub ahead of print]. PMID: 19955201.
11. Wiersinga WM, Prummel MF, Mourits MP, Koornneef L, Buller HR 1991 Classification of the eye changes of Graves' disease. Thyroid 1:357-360.
12. Werner SC 1977 Modification of the classification of the eye changes of Graves' disease. Am J Ophthalmol 83:725-270.
13. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L 1997 Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf ) 47:9-14. (Pubitemid 27313981)
14. Regensburg NI, Kok PH, Zonneveld FW, Baldeschi L, Saeed P, Wiersinga WM, Mourits MP 2008 A new and validated ct-based method for the calculation of orbital soft tissue volumes. Invest Ophthalmol Vis Sci 49:1758-1762.
15. Materialise, Leuven, Belgium. Mimics (version 10.2), 2007.
16. Perros P, Crombie AL, Matthews JN, Kendall-Taylor P 1993 Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol (Oxf ) 38:367-372. (Pubitemid 23105068)
17. Kendler DL, Lippa J, and Rootman J 1993 The initial clinical characteristics of Graves' orbitopathy vary with age and sex. Arch Ophthalmol 111:197-201. (Pubitemid 23053567)
18. Szucs-Farkas Z, Toth J, Kollar J, Galuska L, Burman KD, Boda J, Leovey A, Varga J, Ujhelyi B, Szabo J, Berta A, Nagy EV 2005 Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking. Thyroid 15:146-151. (Pubitemid 40344363)
19. Yu Wai Man CY, Chinnery PF, Griffiths PG 2005 Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders. Neuromuscul Disord 15:17-23. (Pubitemid 41556628)
20. Spencer RF, Porter J 1988 Structural organization of the extraocular muscles. Rev Oculomot Res 2:33-79.
21. Wooten GF, Reis DJ 1972 Blood flow in extraocular muscle of cat. Arch Neurol 26:350-352.
22. Carry MR, Ringel SP, Starcevich JM 1986 Mitochondrial morphometrics of histochemically identified human extraocular muscle fibres. Anat Rec 214:8-16. (Pubitemid 16160039)
23. Chang TS, Johns DR, Walker D, de la Cruz Z, Maumence IH, Green WR 1993 Ocular clinicopathologic study of the mitochondrial encephalomyopathy overlap syndromes. Arch Ophthalmol 111:1254-1262. (Pubitemid 23268788)
24. Fischer MD, Gorospe JR, Felder E, Bogdanovich S, Pedrosa-Domellof F, Ahima RS, Rubinstein NA, Hoffman EP, Khurana TS 2002 Expression profiling reveals metabolic and structural components of extraocularmuscles. Physiol Genomics 9:71-84.